R Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Ryder (R) is not a good buy right now for an impatient buyer. Near-term technicals are neutral-to-soft, options positioning is defensively bearish (puts dominate), and pattern-based odds point to downside over the next week/month. With no Intellectia buy signals today and earnings ahead on 2026-02-11 (pre-market), the risk/reward favors avoiding new entries at current levels (~190.8).
Price is sitting near the pivot (191.484) with tight/converging moving averages—suggesting consolidation rather than a clean uptrend. MACD histogram is negative (-0.419) though contracting, implying downside momentum is fading but still below zero (not yet bullish). RSI(6) is ~50.85 (neutral), offering no oversold bounce signal. Key levels: immediate support S1 ~187.335 then S2 ~184.772; resistance R1 ~195.632 then R2 ~198.195. The provided pattern-probability outlook is unfavorable: ~70% chance of ~-4.2% over the next week and ~-10.61% over the next month.
Intellectia Proprietary Trading Signals
Analyst support still exists despite the recent downgrade: Citi reiterated Buy and raised PT to $218 (2025-12-19); Morgan Stanley kept Overweight and raised PT to $250 (2025-12-08); Wells Fargo initiated Overweight with $210 PT (2025-12-05), highlighting contracted revenues with inflation escalators and mix improvement. Margins improved in the latest reported quarter (gross margin up YoY). If the truck cycle improves in 2026, Ryder is positioned as a relatively defensible way to participate due to contracted pricing.
citing limited absolute upside after a rally and a more cautious near-term view. No supportive news catalysts in the past week. Earnings on 2026-02-11 (pre-market) can introduce event risk and may cap upside until clarity.
Latest quarter: 2025/Q3. Revenue was essentially flat YoY (+0.09% to ~$3.171B). Net income declined (-3.52% to ~$137M), while EPS still rose modestly (+1.54% to 3.29), suggesting some offset from mix/efficiency. Gross margin improved (+3.81% YoY to ~20.97), a constructive trend, but overall growth is not strong enough to override the current bearish/neutral trading signals for an immediate buy.
Recent trend: price targets were raised and coverage was positive through December (Citi PT $218 Buy; Morgan Stanley PT $250 Overweight; Wells Fargo initiated Overweight PT $210), then sentiment cooled with Wolfe downgrading to Peer Perform on 2026-01-08 (no PT) after a run-up and limited perceived upside. Wall Street pros view: Pros—improving business mix, contracted revenue with inflation escalators, leverage to truck recovery. Cons—after-rally valuation/upside constraints, cyclical freight sensitivity, and less compelling near-term upside per Wolfe. Influential trading: no recent congress trading data; hedge funds and insiders show neutral activity.
